Approvals/TGA/SITAGLIPTIN/METFORMIN XR MAPLE 100/1000 sitagliptin (as phosphate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle

Approved

STANDARD

SITAGLIPTIN/METFORMIN XR MAPLE 100/1000 sitagliptin (as phosphate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle

Maple Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: 6e09992338a07e6d
Company: Maple Healthcare Pty Ltd
Type: Standard

Approval Details

Approval Id: 6e09992338a07e6d
Product Name: SITAGLIPTIN/METFORMIN XR MAPLE 100/1000 sitagliptin (as phosphate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle
Artg Id: 443394
Artg Name: SITAGLIPTIN/METFORMIN XR MAPLE 100/1000 sitagliptin (as phosphate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle
Sponsor: Maple Healthcare Pty Ltd
Company Detail Path: /organization/maple-healthcare-pty-ltd
Artg Date: 2025-03-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6e09992338a07e6d

Type

Standard

Back to TGA Approvals